ENDOCRINE - Key Persons
Job Titles:
- Editor of Clinics of North American for Type 2 Diabetes
- Medical Director of the Scripps Diabetes Institute
Dr. Einhorn serves as medical director of the Scripps Diabetes Institute and as clinical professor of medicine at University of California, San Diego, where he made major contributions to the teaching and research programs in endocrinology. He is also advisor to six start-up biotech companies, is associate editor of the Journal of Diabetes, and is a trustee of the famed La Jolla Playhouse.
Dr. Einhorn was and is part of almost every pharmaceutical and device development in diabetes since the early 1980s. Seeing something as a twinkle in a researcher's eye, and then seeing it become a product that helps millions of people has been very rewarding. And writing clinical guidelines that change how people practice is also very gratifying.
Dr. Einhorn is Editor of Clinics of North American for Type 2 Diabetes, Editor for Type 2 Diabetes in a Time of Pandemic for The Royal Society of Medicine Press, and an Associate Editor of the Journal of Diabetes. He consults to government, industry, and the media. He is a Fellow of the American College of Physicians and The American College of Endocrinology. He Co-Chaired the national consensus conferences on insulin resistance syndrome and on pre-diabetes. A list of his most recent contributions can be found here.
Additionally, Dr. Schneider is an accomplished basic and clinical researcher. He completed a PhD with work in pancreatic islet transplantation - with Reinhard Bretzel in Giessen, Europe's first center for human pancreatic islet transplantation - and was subsequently awarded a Fulbright fellowship to undertake research in the field of diabetes and immunology in the lab of Matthias von Herrath at the prestigious "La Jolla Institute for Allergy and Immunology", resulting in several influential research papers in high impact journals, and textbook chapters. Also, Dr. Schneider worked with William "Bill" Hagopian at the "Pacific Northwest Research Institute" Seattle investigating risk scores for the prediction and correct diagnosis of diabetes subtypes as well as environmental factors in the development of Type 1 Diabetes (TEDDY study).
Dr. Schneider is co-investigator on several diabetes research studies, his research interests are focused on Type 1 Diabetes immunology, islet transplantation and technology (artificial pancreas).
In his practice, Dr. Schneider provides state-of-the-art clinical care for patients with diabetes and endocrine disorders including thyroid, adrenal, pituitary, gonadal disorders and bone. He brings broad clinical expertise along with technical skill in thyroid ultrasound, biopsy and radiofrequency ablation, and the latest breakthroughs in diabetes technology.